Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC4 | P56524 | 4/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.50 |
| ▸ | OXTR | P30559 | 1/20 | 0.48 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31500492 | 0.95 | ABCB1 (0.51) | HDAC4ABCB1OXTRHDAC1HDAC6 | |
| SCHEMBL31500491 | 0.95 | ABCB1 (0.51) | HDAC4ABCB1OXTRHDAC1HDAC6 | |
| SCHEMBL29220474 | 0.90 | ABCB1 (0.55) | HDAC4ABCB1OXTR | |
| SCHEMBL30834923 | 0.89 | HDAC4 (0.53) | HDAC4ABCB1OXTR | |
| SCHEMBL29884582 | 0.88 | HDAC4 (0.60) | HDAC4HDAC1HDAC6HDAC8 | |
| SCHEMBL31609176 | 0.88 | HDAC3 (0.59) | HDAC4OXTRHDAC1HDAC6HDAC8 | |
| SCHEMBL31609180 | 0.88 | HDAC3 (0.59) | HDAC4OXTRHDAC1HDAC6HDAC8 | |
| Cyclolinopeptide A SCHEMBL31609181 | 0.87 | ABCB1 (0.54) | HDAC4ABCB1OXTR | |
| SCHEMBL29387556 | 0.86 | ABCB1 (0.57) | HDAC4ABCB1OXTR | |
| SCHEMBL31500489 | 0.85 | ABCB1 (0.51) | HDAC4ABCB1OXTRHDAC1HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3746041-B1 | USE OF CYCLIC PEPTIDES IN COSMETIC | SEDERMA SA (FR) | 2025-06-04 | — | — | EP | claimed |
| EP-3746041-B1 | USE OF CYCLIC PEPTIDES IN COSMETIC | SEDERMA SA (FR) | 2025-06-04 | — | — | EP | disclosed |